脑部放疗,上午比下午敏感许多!
0 B( n V) z5 F" k3 f
! x$ g% v% C+ [, {! K& K. U3 o3 g8 s# T$ y |3 _7 w/ t2 G6 _$ h7 ?
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
! w% f3 N3 [1 `3 i+ T8 X3 a: @- { uGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?: R9 p u% [9 N4 E( j# m
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
4 T# s$ |! h7 s4 f* v4 }SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
\$ l' T* m5 g& {! x$ v4 a, j5 x/ J' O" d4 g7 ^* l' F) q
Abstract
; [* k4 h3 i" DBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time. Q' `: p0 R+ Y, N0 B* u" ~
# Q% L, S( T3 L1 r9 m
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
7 _0 `& i% c5 ]0 @+ S- O: F
: s% r, K) X' F1 k6 k) rRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).( H, p+ k7 t% {( H% W( F1 g
S' H- V9 b7 v& Z
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
: g" p% ^; @/ s! ~: y
( v* S% B$ e$ _7 a) | |